Patient Data
Review H and P, and nurse’s note. Complete the diagram by dragging from the choices area to specify which condition the client is most likely experiencing, two actions the nurse should take to address that condition, and two parameters the nurse should monitor to assess the client’s progress.
The Correct Answer is []
Choice A: Place the client on a cardiorespiratory monitor
Reason: Placing the client on a cardiorespiratory monitor is crucial in this scenario because the client is experiencing heart palpitations, dizziness, and lightheadedness, which are indicative of a potential tachydysrhythmia. A cardiorespiratory monitor will continuously track the heart rate and rhythm, allowing for immediate detection of any abnormal heart rhythms. This is essential for timely intervention and management of any life-threatening arrhythmias. Continuous monitoring also helps in assessing the effectiveness of any treatments administered and in making necessary adjustments.
Choice B: Administer diphenhydramine
Reason: Diphenhydramine is an antihistamine commonly used to treat allergic reactions and symptoms of anaphylaxis. However, in this case, the client does not exhibit symptoms of an allergic reaction or anaphylaxis, such as hives, swelling, or difficulty breathing. The primary concern here is the heart palpitations and dizziness, which are more indicative of a cardiac issue rather than an allergic reaction. Therefore, administering diphenhydramine would not address the underlying problem and is not the appropriate action in this scenario.
Choice C: Give a dose of albuterol
Reason: Albuterol is a bronchodilator used to relieve bronchospasm in conditions like asthma. Although the client has moderate persistent asthma and has been using albuterol, the current symptoms of heart palpitations and dizziness suggest a possible overuse of albuterol, leading to tachydysrhythmia. However, in the context of an acute asthma exacerbation, administering albuterol can still be necessary to manage bronchospasm. It is important to balance the need for bronchodilation with the risk of exacerbating tachydysrhythmia. Therefore, giving a dose of albuterol should be carefully considered and monitored.
Choice D: Anaphylaxis
Reason: Anaphylaxis is a severe, life-threatening allergic reaction that requires immediate treatment with epinephrine. The client does not present with symptoms typical of anaphylaxis, such as hives, swelling, or difficulty breathing. Instead, the symptoms of heart palpitations, dizziness, and lightheadedness are more consistent with a cardiac issue. Additionally, the client’s oxygen saturation is 99% on room air, which is not indicative of anaphylaxis. Therefore, anaphylaxis is not the most likely condition in this scenario.
Choice E: Tachydysrhythmia
Reason: Tachydysrhythmia refers to an abnormal heart rhythm with a rapid rate, which can cause symptoms such as heart palpitations, dizziness, and lightheadedness. The client’s symptoms, along with the history of using multiple doses of albuterol, suggest that she may be experiencing a tachydysrhythmia. Albuterol, a beta-agonist, can cause tachycardia and palpitations, especially when used frequently. Therefore, tachydysrhythmia is the most likely condition the client is experiencing.
Choice F: Anemia
Reason: Anemia is a condition characterized by a deficiency of red blood cells or hemoglobin, leading to symptoms such as fatigue, weakness, and dizziness. While dizziness and lightheadedness can be symptoms of anemia, the client’s presentation of heart palpitations and the context of asthma management with frequent albuterol use point more towards a cardiac issue rather than anemia. Additionally, there is no mention of other common symptoms of anemia, such as pallor or fatigue, in the client’s history and physical examination.
Choice G: Breath sounds
Reason: Monitoring breath sounds is essential in assessing the respiratory status of a client with asthma. Changes in breath sounds can indicate the presence of bronchospasm, airway obstruction, or other respiratory complications. In this scenario, monitoring breath sounds will help assess the effectiveness of albuterol treatment and detect any worsening of asthma symptoms. It is also important to ensure that the client’s respiratory status remains stable while addressing the cardiac issue.
Choice H: Airway edema
Reason: Monitoring for airway edema is important in clients with asthma, as it can indicate inflammation and swelling of the airways, leading to obstruction and difficulty breathing. In this case, while the primary concern is the cardiac symptoms, it is still important to monitor for any signs of airway edema, especially given the client’s history of asthma and recent exacerbation of symptoms. This will help in managing the respiratory aspect of the client’s condition and ensuring comprehensive care.
Choice I: Iron level
Reason: Monitoring iron levels is relevant in the context of anemia, as low iron levels can indicate iron deficiency anemia. However, in this scenario, the client’s symptoms and history do not suggest anemia as the primary issue. The focus should be on monitoring parameters related to the cardiac and respiratory systems, given the client’s presentation of heart palpitations, dizziness, and asthma exacerbation. Therefore, monitoring iron levels is not a priority in this case.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["A","B","D","E"]
Explanation
Choice A: No known allergies
Reason: The absence of known allergies is crucial when administering any medication, including antibiotics like vancomycin. Allergic reactions to antibiotics can range from mild rashes to severe anaphylaxis, which can be life-threatening. In this case, the patient has reported no known allergies, which significantly reduces the risk of an adverse reaction to vancomycin. This makes it safer to proceed with the administration of the antibiotic. Ensuring that the patient has no known allergies is a standard precaution in medical practice to prevent potential allergic reactions.
Choice B: Dosage in safe range
Reason: The dosage of vancomycin must be within a safe range to avoid toxicity. Vancomycin is typically dosed based on the patient’s weight and renal function. For adults, the usual dose is 15-20 mg/kg, administered every 8-12 hours, depending on the severity of the infection and the patient’s renal function. In this scenario, the prescribed dose is 1 gram in 250 mL of 0.9% sodium chloride, which is within the safe range for an adult patient. Administering the correct dosage is essential to ensure the effectiveness of the antibiotic while minimizing the risk of nephrotoxicity and ototoxicity, which are potential side effects of vancomycin.
Choice C: Potassium 4.4 mEq/L (4.4 mmol/L)
Reason: While the potassium level of 4.4 mEq/L is within the normal range (3.5-5.0 mEq/L), it is not directly related to the safety of administering vancomycin. Potassium levels are more relevant to the overall electrolyte balance and cardiac function but do not specifically impact the administration of vancomycin. Therefore, this choice is not as pertinent to the safety of vancomycin administration as the other options.
Choice D: Peripheral IV in large vein
Reason: Administering vancomycin through a peripheral IV in a large vein is important to reduce the risk of phlebitis and irritation. Vancomycin is known to be irritating to veins, and using a large vein helps to dilute the medication more effectively, reducing the risk of vein inflammation. In this case, the peripheral IV was started in the right antecubital with a 20-gauge catheter, which is appropriate for the administration of vancomycin. Ensuring proper IV placement and using a large vein can help prevent complications associated with IV administration of this antibiotic.
Choice E: Used for prophylaxis
Reason: Vancomycin is being used as a prophylactic measure to prevent endocarditis in this patient. Prophylactic use of antibiotics is common in patients undergoing certain surgical procedures, especially those with a history of heart conditions, to prevent bacterial infections. In this case, the patient is undergoing pacemaker insertion, and the use of vancomycin as prophylaxis is appropriate to prevent potential infections. Prophylactic administration of antibiotics like vancomycin is a standard practice to reduce the risk of postoperative infections, particularly in patients with a higher risk of complications.
Choice F: Blood urea nitrogen 17 mg/dl (6.07 mmol/L)
Reason: The blood urea nitrogen (BUN) level of 17 mg/dL is within the normal range (7-20 mg/dL). While BUN levels are important indicators of renal function, they are not directly related to the safety of administering vancomycin in this context. Vancomycin dosing does need to consider renal function, but the BUN level alone does not provide sufficient information to determine the safety of administration. Therefore, this choice is not as directly relevant as the other options.
Correct Answer is A
Explanation
Choice A Reason:
Glucagon is a hormone used to treat severe hypoglycemia (low blood sugar) in individuals with diabetes. Severe hypoglycemia can be life-threatening and requires immediate treatment to raise blood sugar levels. Glucagon works by stimulating the liver to release stored glucose into the bloodstream. It is crucial for clients and their families to recognize the signs of severe hypoglycemia, such as confusion, unconsciousness, or seizures, and to administer glucagon promptly.

Choice B Reason:
Administering glucagon before meals to prevent hyperglycemia is incorrect. Glucagon is not used to prevent high blood sugar levels; it is specifically used to treat low blood sugar levels. Preventing hyperglycemia typically involves insulin administration and dietary management, not glucagon.
Choice C Reason:
While managing blood sugar levels during sick days is important, glucagon is not used for this purpose. Clients are usually advised to monitor their blood sugar levels more frequently and adjust their insulin doses as needed during illness. Glucagon is reserved for emergency situations involving severe hypoglycemia.
Choice D Reason:
Glucagon is not used to treat diabetic ketoacidosis (DKA). DKA is a serious complication of diabetes that requires immediate medical attention and is treated with insulin, fluids, and electrolytes. Administering glucagon would not address the underlying issues of DKA and could potentially worsen the condition.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
